Autoinjectors to 2026


lyophilized injectable drugs  Autoinjectors to 2026  •  April 2018  •  no. ATJ399K •  Price US $3,850



 

The number of drugs available in prefilled syringes as a percentage of all injectable drugs continues to grow. So too does the number of injectable drugs indicated for chronic conditions and self-administration. But suppliers of autoinjectors face several challenges as the market evolves and matures. Continued interest in plastic prefilled syringes will require non-brand specific injector manufacturers to validate that their devices function consistently and safely over the range of these emerging PFS devices – devices with rigidity, barrel lubricity and flexural properties that differ not insignificantly from type 1 glass. They will have to compete – in some cases head-on – with prefilled syringe suppliers, who are increasingly incorporating autoinjector-like ease-of-use features into their PFS designs to differentiate their product lines and in some cases to meet their pharma customer requirements for product-specific syringe designs.

Bar_Graph  Autoinjectors to 2026 Report Brochure(Download PDF)

Blue document  Autoinjector to 2026 Report Order Form (Download PDF)

 

 


Autoinjectors to 2026 – What You Will Learn

  • What autoinjectors can be paired with prefilled syringes for injectable drug delivery; what are the key market segments, market dynamics and market demographics?
  • What are the therapeutic demand drivers and commercial devices in key product segments?
  • What are the design factors, material selection issues, technologies and market development issues?
  • How big is the market? How is it growing? What will it look like in 2026?
  • Who are the leading injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?
  • What is the importance of pharma-device alliances and design partnerships on autoinjector commercialization and market access?
  • What is the impact of wirelessly connected autoinjectors on patient care and market growth?
  • What are the significant economic, technology, and regulatory factors affecting the market for autoinjectors?

 

Autoinjectors to 2026 – Summary of Contents

Executive Summary

 

The Market Opportunity

Delivery Market Dynamics

The Economics of Injectable Drugs

What’s Driving the Growth in Autoinjectors?

Prefilled Syringes Proliferating

The Trend toward Self-Administration

Shifting Demographics

Innovation in Disposable Device Designs

Therapeutic Demand Drivers

Competitive Landscape

Risk Factors

 

Autoinjectors – Commercial Devices

Manual Injection Autoinjectors

Automated Injection Autoinjectors

Reusable Autoinjectors

Disposable Autoinjectors

Variable Dose Autoinjectors

Product Specific Autoinjectors

 

Autoinjector Device Design Factors

Material Selection Issues

Part Counts and Device Cost

Safety Features

Needle Shielding

Needle Insertion Depth

Failsafe Activation

Dose Inspection/Injection Confirmation

Lyophilized Drugs/Reconstitution

Human Engineering/Ergonomics

 

Autoinjector Drug Delivery – Key Therapeutic Sector Analysis

Anticoagulants

Autoimmune Diseases

Rheumatoid Arthritis

Multiple Sclerosis

Psoriasis

Emergency Medicine

Hepatitis

Hematopoietics

Hormones

Reproductive Health

 

Market Factors

Regulatory Issues

Device Branding

Patient Compliance and Ease of Use

Healthcare Economics

 

Company Profiles